Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland.
Van Hung NguyenMansoor AshrafJoaquin F Mould-QuevedoPublished in: Vaccines (2023)
The use of aQIV for adults ≥ 65 years old in Ireland was shown to be highly cost-effective from both payer and societal perspectives.
Keyphrases